Cite
HARVARD Citation
Steiner, T. et al. (2019). Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine. Headache. 59 (4), p. 626. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Steiner, T. et al. (2019). Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine. Headache. 59 (4), p. 626. [Online].